FTC to Sue ‘Big Three’ PBMs for Setting Insulin, Other Drug Prices: WSJ 7/11/2024

FTC Ban That Would Make Switching Jobs Easier Hits Roadblock 7/11/2024

Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Ma... 6/11/2024

Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis 6/11/2024

Sage’s Dalzanemdor Shows Effect in Huntington’s Study, Analysts Say Results ‘Underwhelming’ 6/11/2024

Stada Bags European Rights from Alvotech to Biosimilar of Amgen Blockbusters 6/11/2024

GSK Appeals Delaware Court’s Decision in Zantac Cases as Plaintiff Drops Lawsuit 6/11/2024

Lilly Sees More Zepbound Out-of-Pocket Payments as Obesity Pill Nears Phase III Readout 6/11/2024

Top 5 Companies Hiring in San Diego 4/11/2024

VC Firm Flagship Raises $3.6B to Create, Support 25 ‘Breakthrough’ Companies 7/10/2024

FDA Approves Atopic Dermatitis Label Expansion for Arcutis’ Zoryve Cream 7/10/2024

Amylyx Pivots to GLP-1 Space, Acquires Phase III-Ready Asset from Eiger 7/10/2024

Alnylam Could Challenge Pfizer in ATTR-CM But Experts Want Full Data 7/10/2024

Lilly’s I&I Play, ADC Investment and GLP-1 Momentum Persists 7/10/2024

Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors 7/10/2024

Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia 7/10/2024

Why Is Antimicrobial Resistance Not Getting Much Attention from Biopharma? 7/10/2024

Opinion: To Realize AI’s Benefits, Don’t Lose Sight of Fundamentals 7/10/2024

Adcomm Votes Unanimously for Lilly’s Alzheimer’s Treatment Donanemab 6/10/2024

Moderna’s COVID-Flu Combo Shot Beats Separate Vaccines in Phase III Study 6/10/2024